menu search

Shareholder investigation: halper sadeh llc investigates apgn, kbnt, dm, wtt

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vio...

June 4, 2023, 12:40 pm

Lifshitz law pllc announces investigations of apgn, gnl, rtl, and back

NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) — apexigen, Inc. (NASDAQ: APGN) Lifshitz Law PLLC announces ...

June 4, 2023, 12:17 am

apexigen announces phase 2 data evaluating sotigalimab, its cd40 agonist antibody, in combination with doxorubicin in patients with advanced soft tissue sarcoma presented at the american society of cl

– Marked increases in overall survival observed across soft tissue sarcoma patients – – Demonstrated improvement of median progression free surv...

June 3, 2023, 12:00 pm

apexigen announces phase 2 data evaluating sotigalimab, its cd40 agonist antibody, in combination with doxorubicin in patients with advanced soft tissue sarcoma presented at the american society of cl

– Marked increases in overall survival observed across soft tissue sarcoma patients – – Demonstrated improvement of median progression free surv...

June 3, 2023, 12:00 pm

apexigen announces phase 2 data evaluating sotigalimab, its cd40 agonist antibody, in combination with doxorubicin in patients with advanced soft tissue sarcoma presented at the american society of cl

– Marked increases in overall survival observed across soft tissue sarcoma patients – – Demonstrated improvement of median progression free surv...

June 3, 2023, 12:00 pm

apexigen announces phase 2 data evaluating sotigalimab, its cd40 agonist antibody, in combination with doxorubicin in patients with advanced soft tissue sarcoma presented at the american society of cl

– Marked increases in overall survival observed across soft tissue sarcoma patients – – Demonstrated improvement of median progression free surv...

June 3, 2023, 12:00 pm

apexigen announces phase 2 data evaluating sotigalimab, its cd40 agonist antibody, in combination with doxorubicin in patients with advanced soft tissue sarcoma presented at the american society of cl

– Marked increases in overall survival observed across soft tissue sarcoma patients – – Demonstrated improvement of median progression free surv...

June 3, 2023, 12:00 pm

apexigen (apgn) to get acquired by pyxis oncology, stock up

apexigen (APGN) surges as Pyxis Oncology offers to acquire it for approximately $16 million....

May 25, 2023, 4:32 pm

Pyxis oncology to acquire apexigen

Pyxis Oncology positioned at forefront of Antibody-Drug Conjugate (ADC) development Commercially and clinically validated APXiMAB platform for antibod...

May 24, 2023, 10:45 am

Why is apexigen (apgn) stock up 31% today?

apexigen (NASDAQ: APGN ) stock is rising higher on Wednesday following news of a deal with Pyxis Oncolo...

May 24, 2023, 9:43 am

Are medical stocks lagging apexigen, inc. (apgn) this year?

Here is how apexigen, Inc. (APGN) and Atara Biotherapeutics (ATRA) have performed compared to their sec...

March 3, 2023, 11:18 am

apexigen stock soars after analyst rating, is it time to buy?

apexigen stock is soaring after a bullish analyst rating. This can frequently give penny stocks legitim...

January 10, 2023, 2:39 pm


Search within

Pages Search Results: